Prosecution Insights
Last updated: November 04, 2026

Watchmaker Genomics Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Analysis

Watchmaker Genomics Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is handled by 1 distinct examiner. The prosecution is localized within 1 distinct art unit. This indicates a specific focus for the company's current patent activity. The concentration in 1 art unit suggests that the technical subject matter is being evaluated by a specialized group at the USPTO.

RAYMONDA, MATTHEW HAROLD is the busiest examiner, responsible for 1 pending office action. This action constitutes the total pending workload for the portfolio. Because there is only 1 distinct examiner and 1 distinct art unit, the company's current prosecution outcomes are dependent on this examiner's evaluation. This concentrated activity allows for a targeted approach to the USPTO, but it also means that the success of the current portfolio rests on a single relationship. Practitioners should focus on the specific examination patterns of RAYMONDA, MATTHEW HAROLD to optimize the outcome for this 1 pending office action.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RAYMONDA, MATTHEW HAROLD 1 40.0% +47.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19098542 GENE VARIANT LIBRARIES AND METHODS OF USE THEREOF RAYMONDA, MATTHEW HAROLD 22d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19098542 GENE VARIANT LIBRARIES AND METHODS OF USE THEREOF RAYMONDA, MATTHEW HAROLD 22d overdue

Top Art Units

Art UnitApps
1684 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19098542 GENE VARIANT LIBRARIES AND METHODS OF USE THEREOF RAYMONDA, MATTHEW HAROLD 1684 §103§112 Non-Final OA 22d overdue Pending Apr 02, 2025

Managing Watchmaker Genomics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Watchmaker Genomics Inc. have?

Watchmaker Genomics Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Watchmaker Genomics Inc. applications?

Matthew Harold Raymonda has the most, with 1 of Watchmaker Genomics Inc.'s pending office actions.

What technology area are Watchmaker Genomics Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month